MF
VERA icon

Magnetar Financial’s Vera Therapeutics VERA Stock Holding History

Magnetar Financial’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
6,987
+590
+9% +$22K ﹤0.01% 787
2026
Q1 		$257K Buy
+6,397
New +$276K ﹤0.01% 802
2025
Q2 		– Sell
-16,982
Closed -$408K – 1164
2025
Q1 		$408K Buy
+16,982
New +$546K 0.01% 504
2024
Q3 		– Sell
-18,021
Closed -$652K – 703
2024
Q2 		$652K Buy
+18,021
New +$715K 0.01% 312

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Magnetar Financial's VERA Position: Q2 2026 in Review

Magnetar Financial increased its Vera Therapeutics (VERA) stake by 9.2% in Q2 2026, buying an estimated $22K and bringing the position to 6,987 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Magnetar Financial first reported a position in VERA in Q2 2024 and has held it in 4 quarters since. The position peaked at $652K in Q2 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Magnetar Financial held 6,987 shares of Vera Therapeutics worth $300K as of Q2 2026.
  • Magnetar Financial bought 590 Vera Therapeutics shares in Q2 2026, an estimated $22K.
  • Vera Therapeutics made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #787 holding.
  • Magnetar Financial first reported a position in Vera Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Magnetar Financial's Vera Therapeutics position peaked at $652K in Q2 2024.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.